Targeting issues in the body’s master regulatory system
As a start-up from Flagship Ventures, Foghorn Therapeutics began in a Stanford lab with a woman named Cigall Kadoch
Dr. Kadoch, one of Forbes’ 30 Under 30 in 2014, discovered that changes in the regulatory system of cells appear to be involved in at least 20% of cancers.
The company she co-founded now employs over 30 people in various scientific and operational roles, looking to develop drug candidates for multiple types of cancer and other diseases.
And we’ve been there since the beginning. Working with the start-up team back in 2016, we got to understand the science but also what motivates this passionate group: putting people first.
Beginning with the logo development, an abstract construct of the shape of chromatin and the potential found therein, we built out a complete package of Foghorn’s visual brand identity: from stationery and business cards to Powerpoint templates and website.
We really enjoyed working with the Flagship Ventures team and Foghorn’s CEO Adrian Gottschalk on developing the concept for the company website. They developed an air traffic control metaphor for the science behind Foghorn and we took it from there to use those abstract concepts in imagery and language throughout the site. Kudos to this group of scientists for seeing the impact of concept rather than just the standard science stock imagery and jargon.
Photography: Lara Woolfson, Studio Nouveau